المؤلفون: Christopher J. Colombo, MD, MA, FACP, FCCM, Rhonda E. Colombo, MD, MHS, FACP, FIDSA, Ryan C. Maves, MD, FCCM, FCCP, FIDSA, Angela R. Branche, MD, Stuart H. Cohen, MD, Marie-Carmelle Elie, MD, Sarah L. George, MD, Hannah J. Jang, PhD, RN, CNL, PHN, Andre C. Kalil, MD, MPH, David A. Lindholm, MD, FACP, Richard A. Mularski, MD, MSHS, MCR, ATSF, FCCP, FACP, Justin R. Ortiz, MD, MS, FACP, FCCP, Victor Tapson, MD, C. Jason Liang, PhD, On behalf of the ACTT-1 Study Group, Aneesh K. Mehta, Nadine G. Rouphael, Jessica J. Traenkner, Valeria D Cantos, Ghina Alaaeddine, Barry S. Zingman, Robert Grossberg, Paul F. Riska, Elizabeth Hohmann, Mariam Torres-Soto, Nikolaus Jilg, Helen Y. Chu, Anna Wald, Margaret Green, Annie Luetkemeyer, Pierre-Cedric B. Crouch, Hannah Jang, Susan Kline, Joanne Billings, Brooke Noren, Diego Lopez de Castilla, Jason W. Van Winkle, Francis X. Riedo, Robert W. Finberg, Jennifer P. Wang, Mireya Wessolossky, Kerry Dierberg, Benjamin Eckhardt, Henry J Neumann, Victor Tapson, Jonathan Grein, Fayyaz Sutterwala, Lanny Hsieh, Alpesh N. Amin, Thomas F. Patterson, Heta Javeri, Trung Vu, Roger Paredes, Lourdes Mateu, Daniel A. Sweeney, Constance A. Benson, Farhana Ali, William R. Short, Pablo Tebas, Jessie Torgersen, Giota Touloumi, Vicky Gioukari, David Chien Lye, Sean WX Ong, Norio Ohmagari, Ayako Mikami, Gerd Fätkenheuer, Jakob J. Malin, Philipp Koehler, Andre C. Kalil, LuAnn Larson, Angela Hewlett, Mark G. Kortepeter, C. Buddy Creech, Isaac Thomsen, Todd W. Rice, Babafemi Taiwo, Karen Krueger, Stuart H. Cohen, George R. Thompson, 3rd, Cameron Wolfe, Emmanuel B. Walter, Maria Frank, Heather Young, Ann R. Falsey, Angela R. Branche, Paul Goepfert, Nathaniel Erdmann, Otto O. Yang, Jenny Ahn, Anna Goodman, Blair Merrick, Richard M. Novak, Andrea Wendrow, Henry Arguinchona, Christa Arguinchona, Sarah L. George, Janice Tennant, Robert L. Atmar, Hana M. El Sahly, Jennifer Whitaker, D. Ashley Price, Christopher J. A. Duncan, Simeon Metallidis, Theofilos Chrysanthidis, F. McLellan, Myoung-don Oh, Wan Beom Park, Eu Suk Kim, Jongtak Jung, Justin R. Ortiz, Karen L. Kotloff, Brian Angus, Jack David Germain Seymour, Noreen A. Hynes, Lauren M. Sauer, Neera Ahuja, Kari Nadeau, Patrick E. H. Jackson, Taison D. Bell, Anastasia Antoniadou, Konstantinos Protopapas, Richard T Davey, Jocelyn D. Voell, Jose Muñoz, Montserrat Roldan, Ioannis Kalomenidis, Spyros G. Zakynthinos, Catharine I. Paules, Fiona McGill, Jane Minton, Nikolaos Koulouris, Zafeiria Barmparessou, Edwin Swiatlo, Kyle Widmer, Nikhil Huprikar, Anuradha Ganesan, Guillermo M. Ruiz-Palacios, Alfredo Ponce de León, Sandra Rajme, Justino Regalado Pineda, José Arturo Martinez-Orozco, Mark Holodniy, Aarthi Chary, Timo Wolf, Christoph Stephan, Jan-Christian Wasmuth, Christoph Boesecke, Martin Llewelyn, Barbara Philips, Christopher J. Colombo, Rhonda E. Colombo, David A. Lindholm, Katrin Mende, Tida Lee, Tahaniyat Lalani, Ryan C. Maves, Gregory C. Utz, Jens Lundgren, Marie Helleberg, Jan Gerstoft, Thomas Benfield, Tomas Jensen, Birgitte Lindegaard, Lothar Weise, Lene Knudsen, Isik Johansen, Lone W Madsen, Lars Østergaard, Nina Stærke, Henrik Nielsen, Timothy H. Burgess, Michelle Green, Mat Makowski, Jennifer L. Ferreira, Michael R. Wierzbicki, Tyler Bonnett, Nikki Gettinger, Theresa Engel, Jing Wang, John H. Beigel, Kay M. Tomashek, Seema Nayak, Lori E. Dodd, Walla Dempsey, Effie Nomicos, Marina Lee, Peter Wolff, Rhonda PikaartTautges, Mohamed Elsafy, Robert Jurao, Hyung Koo, Michael Proschan, Dean Follmann, H. Clifford Lane

المصدر: Critical Care Explorations, Vol 3, Iss 7, p e0474 (2021)

مصطلحات موضوعية: Medical emergencies. Critical care. Intensive care. First aid, RC86-88.9

وصف الملف: electronic resource

العلاقة: http://journals.lww.com/10.1097/CCE.0000000000000474Test; https://doaj.org/toc/2639-8028Test

الوصول الحر: https://doaj.org/article/f711c9ef6fc84224b75ad839ed7e126cTest

المؤلفون: Belinda Rivera-Lebron MD, MS, FCCP, Michael McDaniel MD, FACC, FSCAI, Kamran Ahrar MD, MBA, Abdulah Alrifai MD, David M. Dudzinski MD, Christina Fanola MD, MSC, Danielle Blais PharmD, BCPS-AQ Cardiology, David Janicke MD, PhD, Roman Melamed MD, FCCP, Kerry Mohrien PharmD, BCPS, Elizabeth Rozycki PharmD, BCPS, Charles B. Ross MD, FACS, Andrew J. Klein MD, Parth Rali MD, Nicholas R. Teman MD, Leoara Yarboro MD, Eugene Ichinose MD, Aditya M. Sharma MBBS, Jason A. Bartos MD, PhD, Mahir Elder MD, FACC, FSCAI, FCCP, Brent Keeling MD, Harold Palevsky MD, Soophia Naydenov MD, FCCP, Parijat Sen MBBS, MD, Nancy Amoroso MD, Josanna M. Rodriguez-Lopez MD, George A. Davis Pharm D, Rachel Rosovsky MD, Kenneth Rosenfield MD, MHCDS, FACC, FSCAI, Christopher Kabrhel MD, MPH, James Horowitz MD, Jay S. Giri MD, MPH, Victor Tapson MD, FCCP, FRCP, Richard Channick MD

المصدر: Clinical and Applied Thrombosis/Hemostasis, Vol 25 (2019)

مصطلحات موضوعية: Diseases of the circulatory (Cardiovascular) system, RC666-701

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1938-2723Test

الوصول الحر: https://doaj.org/article/f878eb54aa9b4bd79415ba74637761d2Test

المؤلفون: Genentech, Inc.

المساهمون: Victor Tapson, MD, Professor of Medicine

المصدر: Morens DM, Daszak P, Taubenberger JK. Escapg Pandora's Box - Another Novel Coronavus. N Engl J Med. 2020 Apr 2;382(14):1293-1295. do 10.1056/NEJMp2002106. Epub 2020 Feb 26. No abstract avaable.
Tang N, LD, Wang X, Sun Z. Abnormal coagulatn parameters are assocted wh poor prognos patnts wh novel coronavus pneumon. J Thromb Haemost. 2020 Apr;18(4):844-847. do 10.1111/jth.14768. Epub 2020 Mar 13.
Han H, Yang L, L R, L F, Wu KL, LJ, L XH, Zhu CL. Proment changes blood coagulatn of patnts wh SARS-CoV-2 fectn. Cl Chem Lab Med. 2020 Jun 25;58(7):1116-1120. do 10.1515/cclm-2020-0188.
Wang D, Hu B, Hu C, Zhu F, L X, Zhang J, Wang B, Xng H, Cheng Z, Xng Y, Zhao Y, LY, Wang X, Peng Z. Clal Characterts of 138 Hospaled Patnts Wh 2019 Novel Coronavus-fected Pneumon Wuhan, Cha. JAMA. 2020 Mar 17;323(11):1061-1069. do 10.1001/jama.2020.1585. Erratum : JAMA. 2021 Mar 16;325(11):1113.
Yang X, Yu Y, Xu J, Shu H, X J, L H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y. Clal course and outcomes of crally l patnts wh SARS-CoV-2 pneumon Wuhan, Cha: a sgle-centered, retrospecte, observatnal study. Lancet Resp Med. 2020 May;8(5):475-481. do 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24. Erratum : Lancet Resp Med. 2020 Apr;8(4):e26.
Sebag SC, Bastarache JA, Ware LB. Therapeut modulatn of coagulatn and frolys acute lung jury and the acute respatory dtress syndrome. Curr Pharm Btechnol. 2011 Sep;12(9):1481-96. do 10.2174/138920111798281171.
Ware LB, Bastarache JA, Wang L. Coagulatn and frolys human acute lung jury--new therapeut targets? Ke J Med. 2005 Sep;54(3):142-9. do 10.2302/kjm.54.142.
Fan JH. The coagulatn system and pulmonary endothell functn acute lung jury. Mrovasc Res. 2009 Jan;77(1):35-8. do 10.1016/j.mvr.2008.09.002. Epub 2008 Sep 18.
ell S, Koen KB, Fa DS, Mart TR, McLarty J, Maunder RJ. Serl abnormals of fr turnover evolvg adult respatory dtress syndrome. Am J Physl. 1991 Oct;261(4 Pt 1):L240-8. do 10.1152/ajplung.1991.261.4.L240.
Prabhakaran P, Ware LB, Whe KE, Cross MT, Matthay MA, Olman MA. Elevated levels of plasmogen actator hor-1 pulmonary edema flu are assocted wh mortaly acute lung jury. Am J Physl Lung Cell Mol Physl. 2003 Jul;285(1):L20-8. do 10.1152/ajplung.00312.2002. Epub 2003 May 2.
Ware LB, Matthay MA, Parsons PE, Thompson BT, JanuzzJL, Ener MD; Natnal Heart, Lung, and Blood stute Acute Respatory Dtress Syndrome Clal Trls Network. Pathogenet and prognost snance of altered coagulatn and frolys acute lung jury/acute respatory dtress syndrome. Cr Care Med. 2007 Aug;35(8):1821-8. do 10.1097/01.CCM.0000221922.08878.49.
MoallR, Doyle JM, Tahhan HR, Hasan FM, Braman SS, Saldeen T. Frolys crally l patnts. Am Rev Resp D. 1989 Aug;140(2):287-93. do 10.1164/ajrccm/140.2.287.
Texereau J, Pene F, Chhe JD, Rousseau C, Ma JP. portance of hemostat gene polymorphms for suscepty to and outcome of severe seps. Cr Care Med. 2004 May;32(5 Suppl):S313-9. do 10.1097/01.ccm.0000126363.46191.dc.
Hardaway RM, Wlms CH, MarvastM, Fars M, Tseng A, Pon Yanez D, Martez M, Navar J. Preventn of adult respatory dtress syndrome wh plasmogen actator ps. Cr Care Med. 1990 Dec;18(12):1413-8. do 10.1097/00003246-199012000-00021.
Hart DA, Whden P, Green F, Henk J, Woods DE. Partl reversal of establhed bleomyc-duced pulmonary fros by rh-urokase a rat model. Cl vest Med. 1994 Apr;17(2):69-76.
Hardaway RM, Harke H, Tyroch AH, Wlms CH, Vazquez Y, Krause GF. Treatment of severe acute respatory dtress syndrome: a fal report on a phase study. Am Surg. 2001 Apr;67(4):377-82.
Strger KA, Hybertson BM, Cho OJ, Cohen Z, Repe JE. Tsue plasmogen actator (tPA) hs terleuk-1 duced acute lung leak. Free Rad Bl Med. 1998 Jul 15;25(2):184-8. do 10.1016/s0891-5849(98)00047-1.
Burgos AM, Saver JL. Evence that Tenecteplase Nonferr to Alteplase for Acute chem Stroke: Meta-Analys of 5 Randomed Trls. Stroke. 2019 Aug;50(8):2156-2162. do 10.1161/STROKEAHA.119.025080. Epub 2019 Jul 18.
Gulerm A, Yan DJ, Perrr A, MartC. Safety and effacy of tenecteplase versus alteplase acute coronary syndrome: a systemat revw and meta-analys of randomed trls. Arch Med Sc 2016 Dec 1;12(6):1181-1187. do 10.5114/aoms.2016.58929. Epub 2016 Mar 31.
Meyer G, Vaut E, Danays T, AgnellG, BecattC, Beyer-Westendorf J, BluhmkE, Bouvat H, Brenner B, Couturaud F, Dellas C, Empen K, Franca A, Gal N, Geel A, Goldhaber SZ, Jenez D, Kozak M, Kupatt C, Kucher N, Lang , Lanke M, Meneveau N, Pacouret G, PalazzM, Petr A, Pruszczyk P, Rugolotto M, SalvA, Schellong S, Sebbane M, Sobkowz B, Stefanov BS, Thle H, TorbkA, Verschuren F, Konstantes SV; PEHO vestators. Frolys for patnts wh termedte-rk pulmonary embolm. N Engl J Med. 2014 Apr 10;370(15):1402-11. do 10.1056/NEJMoa1302097.
BecattC, AgnellG, SalvA, GronS, PancaldLG, Enea Balsem F, CampanM, GharduzzA, Casazza F; TES Study Group. Bolus tenecteplase for rht ventrle dysfunctn hemodynamally stable patnts wh pulmonary embolm. Thromb Res. 2010 Mar;125(3):e82-6. do 10.1016/j.thromres.2009.09.017. Epub 2009 Oct 14.
Caldott D, Parasam S, Hardg J, Edwards N, Bochner F. Tenecteplase for masse pulmonary embolus. Resuscatn. 2002 Nov;55(2):211-3. do 10.1016/s0300-9572(02)00171-5.
Burkart DJ, Borsa JJ, Anthony JP, Thurlo SR. Thrombolys of occluded perheral arters and ves wh tenecteplase: a pot study. J Vasc terv Radl. 2002 Nov;13(11):1099-102. do 10.1016/s1051-0443(07)61950-2.
Thach J, Tang N, Gando S, Falanga A, Cattaneo M, LevM, Clark C, a T. TH ter guance on recognn and management of coagulopathy COV-19. J Thromb Haemost. 2020 May;18(5):1023-1026. do 10.1111/jth.14810. Epub 2020 Apr 27. No abstract avaable.
Tang N, BaH, Chen X, Gong J, LD, Sun Z. Antoagulant treatment assocted wh decreased mortaly severe coronavus dease 2019 patnts wh coagulopathy. J Thromb Haemost. 2020 May;18(5):1094-1099. do 10.1111/jth.14817. Epub 2020 Apr 27.
Paranjpe Fuster V, Lala A, Russak AJ, Glksberg BS, Lev MA, Charney AW, Narula J, Fayad ZA, Baglla E, Zhao S, NadkarnGN. Assoctn of Treatment Dose Antoagulatn Wh -Hospal Surval Among Hospaled Patnts Wh COV-19. J Am Coll Cardl. 2020 Jul 7;76(1):122-124. do 10.1016/j.jacc.2020.05.001. Epub 2020 May 6. No abstract avaable.
Klok FA, Kru MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, Kapte FHJ, van Paassen J, Stals MAM, Human MV, Endeman H. cence of thrombot complatns crally l U patnts wh COV-19. Thromb Res. 2020 Jul;191:145-147. do 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
Posy J, Goutay J, Caplan M, Parmentr E, Duburcq T, Lassalle F, Jeanprre E, Rauch A, Labreuche J, Susen S; Lle U Haemostas COV-19 Group. Pulmonary Embolm Patnts Wh COV-19: Awareness of an creased Prevalence. Cculatn. 2020 Jul 14;142(2):184-186. do 10.1161/CCULATNAHA.120.047430. Epub 2020 Apr 24. No abstract avaable.
Whmann D, Sperhake JP, Lutgehetmann M, Steurer S, Edler C, Heemann A, Herh F, Mushumba H, Knp Schroder AS, BurdelskC, de Heer G, Nrhaus A, Frgs D, Pfefferle S, Becker H, Bredereke-Wdlg H, de Weerth A, Paschen HR, Shehzadeh-Eggers S, Stang A, Schmdel S, Bokemeyer C, Addo MM, Aepfelbacher M, Puschel K, Kluge S. Autopsy Fdgs and Venous Thromboembolm Patnts Wh COV-19: A Prospecte Cohort Study. Ann tern Med. 2020 Aug 18;173(4):268-277. do 10.7326/M20-2003. Epub 2020 May 6.
Albers GW, Marks MP, Kemp S, Chrtensen S, TsaJP, Ortega-Gutrrez S, McTaggart RA, Torbey MT, K-Tenser M, Lesl-MazwT, Sarraj A, Kasner SE, AnsarSA, Yeatts SD, Hamton S, Mlynash M, He JJ, Zaharchuk G, K S, Carrozzella J, Palesch YY, Demchuk AM, Bammer R, LavorPW, Broderk JP, Lansberg MG; DEFUSE 3 vestators. Thrombectomy for Stroke at 6 to 16 Hours wh Selectn by Perfusn agg. N Engl J Med. 2018 Feb 22;378(8):708-718. do 10.1056/NEJMoa1713973. Epub 2018 Jan 24.
Benedt CR, Refo CJ, Keyt BA, Pakala R, PaonNF, Thomas GR, Bennett WF. New varnt of human tsue plasmogen actator (TPA) wh enhanced effacy and lower cence of bleedg compared wh recombant human TPA. Cculatn. 1995 Nov 15;92(10):3032-40. do 10.1161/01.c.92.10.3032.
Benjam EJ, VanSS, Callaway CW, Chamberla AM, Chang AR, Cheng S, Chve SE, Cushman M, Dellg FN, Deo R, de FerrantSD, Ferguson JF, Fornage M, Glesp C, asCR, Jenez MC, Jordan LC, Judd SE, Lackland D, Lhtman JH, Labeth L, L S, Longenecker CT, Lutsey PL, Mackey JS, Matchar DB, Matsusha K, Mussolo ME, Nas K, O'Flaherty M, Palanppan LP, Pandey A, Pandey DK, Reeves MJ, Rchey MD, Rodruez CJ, Roth GA, Rosamond WD, Sampson UKA, Satou GM, Shah SH, Spartano NL, Tschwell DL, Tsao CW, Voeks JH, Wley JZ, Wks JT, Wu JH, Alger HM, Wong SS, Muntner P; Ameran Heart Assoctn Counc on Epemlogy and Preventn Statts Commtee and Stroke Statts Subcommtee. Heart Dease and Stroke Statts-2018 Update: A Report From the Ameran Heart Assoctn. Cculatn. 2018 Mar 20;137(12):e67-e492. do 10.1161/C.0000000000000558. Epub 2018 Jan 31. No abstract avaable. Erratum : Cculatn. 2018 Mar 20;137(12 ):e493.
Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lgsma HF, Yoo AJ, Schonewle WJ, Vos JA, Nederkoorn PJ, Wermer MJ, van Walderveen MA, Staals J, Hofmeer J, van Oostayen JA, Lycklama a Neholt GJ, Boen J, Brouwer PA, Emmer BJ, de Brun SF, van Dk LC, Kappelle LJ, Lo RH, van Dk EJ, de Vrs J, de Kort PL, van Roo WJ, van den Berg JS, van Hasselt BA, Aerden LA, Dallga RJ, Vser MC, Bot JC, Vroomen PC, EshghO, Schreuder TH, Heboer RJ, Keer K, Tlbeek AV, den Hertog HM, Gerrs DG, van den Berg-Vos RM, Karas GB, Steyerberg EW, Flach HZ, Marquerg HA, Sprengers ME, Jennkens SF, Beenen LF, van den Berg R, Koudstaal PJ, van Zwam WH, Roos YB, van der Lugt A, van Oostenbrugge RJ, Majo CB, Dpel DW; MR CLEAN vestators. A randomed trl of traarterl treatment for acute chem stroke. N Engl J Med. 2015 Jan 1;372(1):11-20. do 10.1056/NEJMoa1411587. Epub 2014 Dec 17. Erratum : N Engl J Med. 2015 Jan 22;372(4):394.
Bard A, Huang X, McElduff P, LevCR, Campbell BC, CherellBK, Kalladka D, Moreton FC, Ford Blad CF, Dav SM, Donnan GA, Mu KW, Parsons MW. pact of Computed Tomography Perfusn agg on the Response to Tenecteplase chem Stroke: Analys of 2 Randomed Controlled Trls. Cculatn. 2017 Jan 31;135(5):440-448. do 10.1161/CCULATNAHA.116.022582. Epub 2016 Dec 13.
Campbell BC, Mchell PJ, Kle TJ, Dewey HM, Churov L, YassN, Yan B, Dowlg RJ, Parsons MW, Oxley TJ, Wu TY, Brooks M, Spson MA, Meff F, LevCR, Krause M, Harrgton TJ, Faulder KC, Stefort BS, Prlger M, Ang T, Scroop R, Barber PA, McGuness B, Weratne T, Phan TG, Chong W, Chandra RV, Blad CF, Badve M, Re H, de Vlrs L, Ma H, Desmond PM, Donnan GA, Dav SM; EXTEND- vestators. Endovascular therapy for chem stroke wh perfusn-agg selectn. N Engl J Med. 2015 Mar 12;372(11):1009-18. do 10.1056/NEJMoa1414792. Epub 2015 Feb 11.
From the Ameran Assoctn of Neurologal Surgeons (AANS), Ameran Socty of Neuroradlogy (ASNR), Cardvascular and terventnal Radlogy Socty of Europe (CSE), Canadn terventnal Radlogy Assoctn (CA), Congress of Neurologal Surgeons (CNS), European Socty of Mally vase Neurologal Therapy (ESMT), European Socty of Neuroradlogy (ESNR), European Stroke Organatn (ESO), Socty for Cardvascular Anggraphy and terventns (SCA, Socty of terventnal Radlogy (S), Socty of Neuroterventnal Surgery (SN), and World Stroke Organatn (WSO); Sacks D, Baxter B, Campbell BCV, Carpenter JS, Cognard C, Dpel D, Eesa M, Fcher U, Hausegger K, Hsch JA, Shazam Hussa M, Jansen O, Jayaraman MV, KhalessAA, Kluck BW, Lave S, Meyers PM, Ramee S, Rufenacht DA, Schmer CM, Vorwerk D. Multocty Consensus Qualy provement Reved Consensus Statement for Endovascular Therapy of Acute chem Stroke. t J Stroke. 2018 Aug;13(6):612-632. do 10.1177/1747493018778713. Epub 2018 May 22. No abstract avaable.
Churov L, Arnup S, Johns H, Leung T, Roberts S, Campbell BC, Dav SM, Donnan GA. An proved method for sple, assumptn-free ordal analys of the modd Rank Scale usg generaled odds rats. t J Stroke. 2014 Dec;9(8):999-1005. do 10.1111/s.12364. Epub 2014 Sep 4.
Coutts SB, Dubuc V, Mandz J, Kenney C, Demchuk AM, Smh EE, Subramanm S, Goyal M, Pat S, Menon BK, Barber PA, DowlatshahD, Fld T, AsdaghN, Camden MC, Hl MD; TEMPO-1 vestators. Tenecteplase-tsue-type plasmogen actator evaluatn for mor chem stroke wh proven occlusn. Stroke. 2015 Mar;46(3):769-74. do 10.1161/STROKEAHA.114.008504. Epub 2015 Feb 12.
DeMets DL, Lan KK. ter analys: the alpha spendg functn approach. Stat Med. 1994 Jul 15-30;13(13-14):1341-52; dcussn 1353-6. do 10.1002/s.4780131308.
Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, BluhmkE, Brott T, Cohen G, Dav S, Donnan G, Grotta J, Howard G, Kaste M, Koga M, von Kummer R, Lansberg M, Ldley R Murray G, Olot JM, Parsons M, Tley B, TonD, Toyoda K, Wahlgren N, Wardlaw J, Wheley W, del Zoppo GJ, Baent C, Sandercock P, Hacke W; Stroke Thrombolys Trlts' Collaborate Group. Effect of treatment delay, age, and stroke severy on the effects of travenous thrombolys wh alteplase for acute chaem stroke: a meta-analys of dual patnt data from randomed trls. Lancet. 2014 Nov 29;384(9958):1929-35. do 10.1016/S0140-6736(14)60584-5. Epub 2014 Aug 5.
Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, Roy D, Jov TG, Wlsky RA, Sapkota BL, DowlatshahD, FreDF, Kamal NR, Montanera WJ, Poppe AY, Ryckborst KJ, Sver FL, Shua A, TamprD, Wlms D, Bang OY, Baxter BW, Burns PA, Choe H, Heo JH, Holmstedt CA, Jankowz B, Kelly M, Lares G, Mandz JL, Shankar J, Sohn S Swartz RH, Barber PA, Coutts SB, Smh EE, Morrh WF, Wel A, Subramanm S, Mha AP, Wong JH, Loweron MW, SajobTT, Hl MD; ESCAPE Trl vestators. Randomed assessment of rap endovascular treatment of chem stroke. N Engl J Med. 2015 Mar 12;372(11):1019-30. do 10.1056/NEJMoa1414905. Epub 2015 Feb 11.
Haley EC Jr, Lyden PD, Johnston KC, Hemmen TM; TNK Stroke vestators. A pot dose-escalatn safety study of tenecteplase acute chem stroke. Stroke. 2005 Mar;36(3):607-12. do 10.1161/01.STR.0000154872.73240.e9. Epub 2005 Feb 3.
Haley EC Jr, Thompson JL, Grotta JC, Lyden PD, Hemmen TG, Brown DL, Fanale C, Lman R, KwtkowskTG, Llas RH, Leve SR, Johnston KC, Buchsbaum R, Levy G, Lev B; Tenecteplase Stroke vestators. Phase B/trl of tenecteplase acute chem stroke: results of a prematurely termated randomed clal trl. Stroke. 2010 Apr;41(4):707-11. do 10.1161/STROKEAHA.109.572040. Epub 2010 Feb 25.
Howard G, Waller JL, Voeks JH, Howard VJ, Jauch EC, Lees KR, Nhols FT, Rahlfs VW, Hess DC. A sple, assumptn-free, and clally terpretable approach for analys of modd Rank outcomes. Stroke. 2012 Mar;43(3):664-9. do 10.1161/STROKEAHA.111.632935. Epub 2012 Feb 16.
Huang X, CherellBK, Lloyd SM, Kalladka D, Moreton FC, SduA, Ford Mu KW. Alteplase versus tenecteplase for thrombolys after chaem stroke (ATTEST): a phase 2, randomed, open-label, blded endpot study. Lancet Neurol. 2015 Apr;14(4):368-76. do 10.1016/S1474-4422(15)70017-7. Epub 2015 Feb 26.
Huang X, Macaac R, Thompson JL, Lev B, Buchsbaum R, Haley EC Jr, LevC, Campbell B, Blad C, Parsons M, Mu KW. Tenecteplase versus alteplase stroke thrombolys: An dual patnt data meta-analys of randomed controlled trls. t J Stroke. 2016 Jul;11(5):534-43. do 10.1177/1747493016641112. Epub 2016 Apr 5.
Jov TG, Lbeskd DS, Gupta R, Rymer M, RaA, Zaat OO, Abou-Chebl A, Baxter B, Levy E Barreto A, Noguea RG. agg-based endovascular therapy for acute chem stroke due to proxal tracranl anterr cculatn occlusn treated beyond 8 hours from te last seen well: retrospecte multenter analys of 237 consecute patnts. Stroke. 2011 Aug;42(8):2206-11. do 10.1161/STROKEAHA.110.604223. Epub 2011 Jul 21.
Jov TG, Chamorro A, Cobo E, de Muel MA, Mola CA, Rova A, San Roman L, Serena J, Ablea S, Ro M, Mlan M, Urra X, Cardona P, Lopez-Canc E, Tomasello A, Castano C, Blasco J, Aja L, Dorado L, Quesada H, Rubra M, Hernandez-Perez M, Goyal M, Demchuk AM, von Kummer R, Gallofre M, Davalos A; REVASCAT Trl vestators. Thrombectomy wh 8 hours after symptom onset chem stroke. N Engl J Med. 2015 Jun 11;372(24):2296-306. do 10.1056/NEJMoa1503780. Epub 2015 Apr 17.
Kate M, Wannamaker R, Kamble H, Rz P, G LC, Buck B, Jeerakath T, Smyth P, Shua A, Emery D, Butcher K. Penumbral agg-Based Thrombolys wh Tenecteplase Feasle up to 24 Hours after Symptom Onset. J Stroke. 2018 Jan;20(1):122-130. do 10.5853/jos.2017.00178. Epub 2018 Jan 31. Erratum : J Stroke. 2018 Sep;20(3):415.
Lansberg MG, Cereda CW, Mlynash M, Mhra NK, oue M, Kemp S, Chrtensen S, Straka M, Zaharchuk G, Marks MP, Bammer R, Albers GW; Dfusn and Perfusn agg Evaluatn for Understandg Stroke Evolutn 2 (DEFUSE 2) Study vestators. Response to endovascular reperfusn not te-dependent patnts wh salvageable tsue. Neurology. 2015 Aug 25;85(8):708-14. do 10.1212/WNL.0000000000001853. Epub 2015 Jul 29.
Logallo N, Kvtad CE, Thomassen L. Therapeut Potentl of Tenecteplase the Management of Acute chem Stroke. CNS Drugs. 2015;29(10):811-8. do 10.1007/s40263-015-0280-9.
Logallo N, Novotny V, Assmus J, Kvtad CE, Alteheld L, Ronng OM, Thommessen B, Amthor KF, le-Hansen H, Kurz M, Tobro H, Kaur K, Stankwz M, Carlsson M, Morsund A, ula T, Aamodt AH, Lund C, Naess H, Waje-Andreassen U, Thomassen L. Tenecteplase versus alteplase for management of acute chaem stroke (NOR-TEST): a phase 3, randomed, open-label, blded endpot trl. Lancet Neurol. 2017 Oct;16(10):781-788. do 10.1016/S1474-4422(17)30253-3. Epub 2017 Aug 2.
Noguea RG, Jadhav AP, Haussen DC, Bonafe A, Budz RF, Bhuva P, Yavagal DR, Ro M, Cognard C, Hanel RA, Sa CA, Hassan AE, Mlan M, Levy E Mchell P, Chen M, Englh JD, Shah QA, Sver FL, Perea VM, Mehta BP, Baxter BW, Abraham MG, Cardona P, Veznedaroglu E, Hellger FR, Feng L, KmanJF, Lopes DK, Jankowz BT, Frankel MR, Costalat V, Vora NA, Yoo AJ, Mal AM, Furlan AJ, Rubra M, Aghaebrah A, Olot JM, Tekle WG, Shlds R, Graves T, Lew RJ, Smh WS, Lbeskd DS, Saver JL, Jov TG; DAWN Trl vestators. Thrombectomy 6 to 24 Hours after Stroke wh a Mmatch between Def and farct. N Engl J Med. 2018 Jan 4;378(1):11-21. do 10.1056/NEJMoa1706442. Epub 2017 Nov 11.
Parsons MW, LevCR. Reperfusn trls for acute chaem stroke. Lancet. 2012 Aug 25;380(9843):706-8. do 10.1016/S0140-6736(12)61043-5. Epub 2012 Jun 28. No abstract avaable.
Powers WJ, Rabste AA, Ackerson T, Adeoye OM, Bambak NC, Becker K, Bler J, Brown M, Demaerschalk BM, Hoh B, Jauch EC, Kwell CS, Lesl-MazwTM, Ovbgele B, Scott PA, Sheth KN, Southerland AM, Summers DV, Tschwell DL; Ameran Heart Assoctn Stroke Counc. 2018 Gueles for the Early Management of Patnts Wh Acute chem Stroke: A Guele for Healthcare Professnals From the Ameran Heart Assoctn/Ameran Stroke Assoctn. Stroke. 2018 Mar;49(3):e46-e110. do 10.1161/STR.0000000000000158. Epub 2018 Jan 24. Erratum : Stroke. 2018 Mar;49(3):e138. Stroke. 2018 Apr 18;:
Saver JL, Goyal M, Bonafe A, Dner HC, Levy E Perea VM, Albers GW, Cognard C, Cohen DJ, Hacke W, Jansen O, Jov TG, Mattle HP, Noguea RG, SduAH, Yavagal DR, Devl TG, Lopes DK, Reddy V, du Mesn de Rochemont R, Jahan R; SWT PRE vestators. Solae wh the tentn for Thrombectomy as Prary Endovascular Treatment for Acute chem Stroke (SWT PRE) trl: protocol for a randomed, controlled, multenter study comparg the Solae revascularatn deve wh tPA wh tPA alone acute chem stroke. t J Stroke. 2015 Apr;10(3):439-48. do 10.1111/s.12459.
Ovbgele B, Goldste LB, Hasha RT, Howard VJ, Johnston SC, Khavjou OA, Lackland DT, Lhtman JH, Mohl S, Sacco RL, Saver JL, Trogdon JG; Ameran Heart Assoctn Advocacy Coordatg Commtee and Stroke Counc. Forecastg the future of stroke the Uned States: a poly statement from the Ameran Heart Assoctn and Ameran Stroke Assoctn. Stroke. 2013 Aug;44(8):2361-75. do 10.1161/STR.0b013e31829734f2. Epub 2013 May 22. Erratum : Stroke. 2015 Jul;46(7):e179.
Low-Dose Tenecteplase in Covid-19 Patients With Acute Pulmonary Embolism: A Randomized, Double-Blind, Placebo-Controlled Trial

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04558125Test

Other URLs: http://ncovid2019.liveTest
http://www.acc.org/latest-in-cardiology/ten-points-to-remember/2018/01/29/12/45/2018-guidelines-for-the-early-management-of-strokeTest
https://thrombosisuk.org/downloads/T&H%20and%20COVID.pdfTest
https://doi.org/10.1101/2020.04.30.20076703Test
https://clinicaltrials.gov/ct2/show/NCT04359277Test
https://clinicaltrials.gov/ct2/show/NCT04345848Test
https://clinicaltrials.gov/ct2/show/NCT04344756Test
https://www.researchgate.net/publication/340140994_Risk_assessment_of_venous_thromboembolism_and_bleeding_in_COVID-19_patientsTest
https://www.researchgate.net/publication/339939319_Clinical_Pathology_of_Critical_Patient_with_Novel_Coronavirus_Pneumonia_COVID-19_Pulmonary_Fibrosis_and_Vascular_Changes_including_Microthrombosis_FormationTest
https://www.semanticscholar.org/paper/Generalized-Odds-Ratios-for-Ordinal-Data-Agresti/f7ac23e686de751706146f8dd926d1f03d1b0255Test

المؤلفون: Bristol-Myers Squibb

المساهمون: Victor Tapson, MD, Director, Clinical Research for the Women's Guild Lung Institute; Director, Venous Thromboembolism and Pulmonary Vascular Disease Research Program; Associate Director, Pulmonary and Critical Care Division

المصدر: Roger VL, Go AS, Lloyd-Jones DM, Benjam EJ, Berry JD, Borden WB, Bravata DM, DaS, Ford ES, Fox CS, Fullerton HJ, Glesp C, Hapern SM, He JA, Howard VJ, Ksela BM, Ktner SJ, Lackland DT, Lhtman JH, Labeth LD, Makuc DM, Marcus GM, MarellA, Matchar DB, Moy CS, Mozaffarn D, Mussolo ME, Nhol G, Paynter NP, Solan EZ, Sorl PD, Sotoodehn N, Turan TN, VanSS, Wong ND, Woo D, Turner MB; Ameran Heart Assoctn Statts Commtee and Stroke Statts Subcommtee. Heart dease and stroke statts--2012 update: a report from the Ameran Heart Assoctn. Cculatn. 2012 Jan 3;125(1):e2-e220. do 10.1161/C.0b013e31823ac046. Epub 2011 Dec 15. No abstract avaable. Erratum : Cculatn. 2012 Jun 5;125(22):e1002.
Beckman MG, Hooper WC, Crchley SE, Ortel TL. Venous thromboembolm: a publ health concern. Am J Prev Med. 2010 Apr;38(4 Suppl):S495-501. do 10.1016/j.amepre.2009.12.017.
Layh DT, Tapson VF. Pharmacolog hemodynam support masse pulmonary embolm. Chest. 1997 Jan;111(1):218-24. do 10.1378/chest.111.1.218. No abstract avaable.
Goldhaber SZ, VanL, De Rosa M. Acute pulmonary embolm: clal outcomes the ternatnal Cooperate Pulmonary Embolm Regtry (OPER). Lancet. 1999 Apr 24;353(9162):1386-9. do 10.1016/s0140-6736(98)07534-5.
Konstantes SV, TorbkA, AgnellG, Danch N, Fzmaure D, Gal N, Gbs JS, Human MV, Humbert M, Kucher N, Lang Lanke M, Lekak J, Maack C, Mayer E, Meneveau N, Perrr A, Pruszczyk P, Rasmussen LH, Schdler TH, Sv P, Vonk Noordegraaf A, Zamorano JL, ZompatorM; Task Force for the Dgnos and Management of Acute Pulmonary Embolm of the European Socty of Cardlogy (ESC). 2014 ESC gueles on the dgnos and management of acute pulmonary embolm. Eur Heart J. 2014 Nov 14;35(43):3033-69, 3069a-3069k. do 10.1093/eurheartj/ehu283. Epub 2014 Aug 29. No abstract avaable. Erratum : Eur Heart J. 2015 Oct 14;36(39):2666. Eur Heart J. 2015 Oct 14;36(39):2642.
Kohn CG, Mearns ES, Parker MW, Hernandez AV, Coleman C Prognost accuracy of clal predtn rules for early post-pulmonary embolm all-cause mortaly: a barte meta-analys. Chest. 2015 Apr;147(4):1043-1062. do 10.1378/chest.14-1888.
Dalla-Volta S, Palla A, Santolandro A, GntC, Pengo V, VlO, Zonz P, ZanuttD, BarbaresF, AgnellG, et al. PAS 2: alteplase combed wh hepar versus hepar the treatment of acute pulmonary embolm. Plasmogen actator aln multenter study 2. J Am Coll Cardl. 1992 Sep;20(3):520-6. do 10.1016/0735-1097(92)90002-5.
Meyer G, Vaut E, Danays T, AgnellG, BecattC, Beyer-Westendorf J, BluhmkE, Bouvat H, Brenner B, Couturaud F, Dellas C, Empen K, Franca A, Gal N, Geel A, Goldhaber SZ, Jenez D, Kozak M, Kupatt C, Kucher N, Lang , Lanke M, Meneveau N, Pacouret G, PalazzM, Petr A, Pruszczyk P, Rugolotto M, SalvA, Schellong S, Sebbane M, Sobkowz B, Stefanov BS, Thle H, TorbkA, Verschuren F, Konstantes SV; PEHO vestators. Frolys for patnts wh termedte-rk pulmonary embolm. N Engl J Med. 2014 Apr 10;370(15):1402-11. do 10.1056/NEJMoa1302097.
Chatterjee S, Chakraborty A, Weberg Kadak M, Wensky RL, Sardar P, KumbhanDJ, Mukherjee D, Jaff MR, GJ. Thrombolys for pulmonary embolm and rk of all-cause mortaly, major bleedg, and tracranl hemorrhage: a meta-analys. JAMA. 2014 Jun 18;311(23):2414-21. do 10.1001/jama.2014.5990.
MartC, John G, Konstantes S, Combescure C, Sanchez O, Lanke M, Meyer G, Perrr A. System thrombolyt therapy for acute pulmonary embolm: a systemat revw and meta-analys. Eur Heart J. 2015 Mar 7;36(10):605-14. do 10.1093/eurheartj/ehu218. Epub 2014 Jun 10.
Daley MJ, Murthy MS, Peterson EJ. Bleedg rk wh system thrombolyt therapy for pulmonary embolm: scope of the problem. Ther Adv Drug Saf. 2015 Apr;6(2):57-66. do 10.1177/2042098615572333.
Kearon C, Akl EA, Ornelas J, Blaas A, Jenez D, Bounameaux H, Human M, Kg CS, Morr TA, Sood N, Stevens SM, Vtch JRE, Wells P, Woller SC, Moores L. Anthrombot Therapy for VTE Dease: CHEST Guele and Expert Panel Report. Chest. 2016 Feb;149(2):315-352. do 10.1016/j.chest.2015.11.026. Epub 2016 Jan 7. Erratum : Chest. 2016 Oct;150(4):988.
Sors H, Pacouret G, Azarn R, Meyer G, Charbonnr B, Sonneau G. Hemodynam effects of bolus vs 2-h fusn of alteplase acute masse pulmonary embolm. A randomed controlled multenter trl. Chest. 1994 Sep;106(3):712-7. do 10.1378/chest.106.3.712.
Goldhaber SZ, AgnellG, Leve MN. Reduced dose bolus alteplase vs conventnal alteplase fusn for pulmonary embolm thrombolys. An ternatnal multenter randomed trl. The Bolus Alteplase Pulmonary Embolm Group. Chest. 1994 Sep;106(3):718-24. do 10.1378/chest.106.3.718.
Wang C, ZhaZ, Yang Y, Wu Q, Cheng Z, Lng L, DaH, Huang K, Lu W, Zhang Z, Cheng X, Shen YH; Cha Venous Thromboembolm (VTE) Study Group. Effacy and safety of low dose recombant tsue-type plasmogen actator for the treatment of acute pulmonary thromboembolm: a randomed, multenter, controlled trl. Chest. 2010 Feb;137(2):254-62. do 10.1378/chest.09-0765. Epub 2009 Sep 9.
Zhang Z, ZhaZG, Lng LR, L FF, Yang YH, Wang C. Lower dosage of recombant tsue-type plasmogen actator (rt-PA) the treatment of acute pulmonary embolm: a systemat revw and meta-analys. Thromb Res. 2014 Mar;133(3):357-63. do 10.1016/j.thromres.2013.12.026. Epub 2013 Dec 23.
Anderson CS, Robson T, Ldley R Ara H, Lavados PM, Lee TH, Broderk JP, Chen X, Chen G, Sharma VK, K JS, Thang NH, Cao Y, Parsons MW, LevC, Huang Y, Olavarr VV, Demchuk AM, Bath PM, Donnan GA, Marts S, Pontes-Neto OM, Sva F, RcS, Roffe C, Pandn J, Blot L, Woodward M, LQ, Wang X, Wang J, Chalmers J; ENCHANTED vestators and Coordators. Low-Dose versus Standard-Dose travenous Alteplase Acute chem Stroke. N Engl J Med. 2016 Jun 16;374(24):2313-23. do 10.1056/NEJMoa1515510. Epub 2016 May 10. Erratum : N Engl J Med. 2018 Apr 12;378(15):1465-1466.
Leve M, Hsh J, Wez J, Crukshank M, Neemeh J, Turp AG, Gent M. A randomed trl of a sgle bolus dosage regen of recombant tsue plasmogen actator patnts wh acute pulmonary embolm. Chest. 1990 Dec;98(6):1473-9. do 10.1378/chest.98.6.1473.
Ucar EY. Update on Thrombolyt Therapy Acute Pulmonary Thromboembolm. Eurasn J Med. 2019 Jun;51(2):186-190. do 10.5152/eurasnjmed.2019.19291.
Kucher N, Boekstegers P, Muller OJ, Kupatt C, Beyer-Westendorf J, Hezer T, Tebbe U, Horstkotte J, Muller R, Blessg E, Gre M, Lange P, Hoffmann RT, Werth S, Barmeyer A, Hartel D, Grunwald H, Empen K, Baumgartner Randomed, controlled trl of ultrasound-assted catheter-dected thrombolys for acute termedte-rk pulmonary embolm. Cculatn. 2014 Jan 28;129(4):479-86. do 10.1161/CCULATNAHA.113.005544. Epub 2013 Nov 13.
Pzza G, Hohlfelder B, Jaff MR, Ourl K, Engelhardt TC, Sterlg KM, Jones NJ, Gurley JC, Bhatheja R, Kennedy RJ, GoswamN, Natarajan K, Rundback J, Sad , L SK, Bhalla N, Raja ML, Westock BS, Cynamon J, ElmasrFF, Garc MJ, Kumar M, AyerdJ, Soukas P, Kuo W, L PY, Goldhaber SZ; SEATTLE vestators. A Prospecte, Sgle-Arm, Multenter Trl of Ultrasound-Facated, Catheter-Dected, Low-Dose Frolys for Acute Masse and Submasse Pulmonary Embolm: The SEATTLE Study. JACC Cardvasc terv. 2015 Aug 24;8(10):1382-1392. do 10.1016/j.jc.2015.04.020.
Tapson VF, Sterlg K, Jones N, Elder M, Trathy U, Brower J, Mahol RL, Ross CB, Natarajan K, Fong P, Greenspon L, Tamaddon H, Pacha AR, Engelhardt T, Katopod J, Marques V, Sharp ASP, Pzza G, Goldhaber SZ. A Randomed Trl of the Optum Duratn of Acoust Pulse Thrombolys Procedure Acute termedte-Rk Pulmonary Embolm: The OPTALYSE PE Trl. JACC Cardvasc terv. 2018 Jul 23;11(14):1401-1410. do 10.1016/j.jc.2018.04.008.
SharM, Bay C, Schwartz F, SkrockL. Safe-dose thrombolys plus raroxaban for moderate and severe pulmonary embolm: dr, drug, and dcharge. Cl Cardl. 2014 Feb;37(2):78-82. do 10.1002/clc.22216. Epub 2013 Oct 7.
AgnellG, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, PorcarA, Raskob GE, Wez J AMPLY-EXT vestators. Apaban for extended treatment of venous thromboembolm. N Engl J Med. 2013 Feb 21;368(8):699-708. do 10.1056/NEJMoa1207541. Epub 2012 Dec 8.
AgnellG, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Maskwz U, Pak R, Thompson J, Raskob GE, Wez J AMPLY vestators. Oral apaban for the treatment of acute venous thromboembolm. N Engl J Med. 2013 Aug 29;369(9):799-808. do 10.1056/NEJMoa1302507. Epub 2013 Jul 1.
Rby RA, Stasopoulos DM. (2005) Generaled adde models for locatn, scale and shape. Journal of the Royal Stattal Socty: Sers C (Appld Statts). 54(3):507-54.
Heo YA. Andexanet Alfa: Fst Global Approval. Drugs. 2018 Jul;78(10):1049-1055. do 10.1007/s40265-018-0940-4. Erratum : Drugs. 2018 Aug;78(12):1285.
Vkers AJ. The use of percentage change from basele as an outcome a controlled trl stattally effnt: a sulatn study. BMC Med Res Methodol. 2001;1:6. do 10.1186/1471-2288-1-6. Epub 2001 Jun 28.
van Buuren S, Fredrs M. Worm plot: a sple dgnost deve for modellg growth reference curves. Stat Med. 2001 Apr 30;20(8):1259-77. do 10.1002/s.746.
R Core Team (2018). A language and envonment for stattal computg. R Foundatn for Stattal Computg, Vnna, Austr.
Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03988842Test